FR2426470A1 - Medicament immunobiotherapique contre des maladies infectieuses des voies respiratoires - Google Patents

Medicament immunobiotherapique contre des maladies infectieuses des voies respiratoires

Info

Publication number
FR2426470A1
FR2426470A1 FR7913157A FR7913157A FR2426470A1 FR 2426470 A1 FR2426470 A1 FR 2426470A1 FR 7913157 A FR7913157 A FR 7913157A FR 7913157 A FR7913157 A FR 7913157A FR 2426470 A1 FR2426470 A1 FR 2426470A1
Authority
FR
France
Prior art keywords
nctc
respiratory tract
immunobiotherapic
infectious diseases
against infectious
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7913157A
Other languages
English (en)
French (fr)
Other versions
FR2426470B1 (enrdf_load_stackoverflow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OM LAB SA
Original Assignee
OM LAB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4299594&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2426470(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by OM LAB SA filed Critical OM LAB SA
Publication of FR2426470A1 publication Critical patent/FR2426470A1/fr
Application granted granted Critical
Publication of FR2426470B1 publication Critical patent/FR2426470B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR7913157A 1978-05-26 1979-05-23 Medicament immunobiotherapique contre des maladies infectieuses des voies respiratoires Granted FR2426470A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH580578A CH633188A5 (fr) 1978-05-26 1978-05-26 Medicament contre des maladies infectieuses des voies respiratoires.

Publications (2)

Publication Number Publication Date
FR2426470A1 true FR2426470A1 (fr) 1979-12-21
FR2426470B1 FR2426470B1 (enrdf_load_stackoverflow) 1983-08-05

Family

ID=4299594

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7913157A Granted FR2426470A1 (fr) 1978-05-26 1979-05-23 Medicament immunobiotherapique contre des maladies infectieuses des voies respiratoires

Country Status (15)

Country Link
JP (1) JPS54154509A (enrdf_load_stackoverflow)
BE (1) BE876164A (enrdf_load_stackoverflow)
CH (1) CH633188A5 (enrdf_load_stackoverflow)
CS (1) CS222673B2 (enrdf_load_stackoverflow)
DD (1) DD143729A5 (enrdf_load_stackoverflow)
DE (1) DE2917730C2 (enrdf_load_stackoverflow)
ES (1) ES480448A1 (enrdf_load_stackoverflow)
FR (1) FR2426470A1 (enrdf_load_stackoverflow)
GB (1) GB2021415B (enrdf_load_stackoverflow)
HU (1) HU180005B (enrdf_load_stackoverflow)
IT (1) IT1116213B (enrdf_load_stackoverflow)
PL (1) PL126416B1 (enrdf_load_stackoverflow)
PT (1) PT69674A (enrdf_load_stackoverflow)
RO (1) RO78451A (enrdf_load_stackoverflow)
YU (1) YU41864B (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550707A1 (fr) * 1983-08-17 1985-02-22 Lipha Medicament immunomodulateur d'origine biologique et son procede de preparation

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH680045A5 (enrdf_load_stackoverflow) * 1990-02-16 1992-06-15 Om Lab Sa
CH685498A5 (fr) * 1992-02-14 1995-07-31 Om Lab Sa Extrait de macromolécules bactériennes, procédé pour sa préparation et composition pharmaceutique contenant cet extrait.
WO1997045530A1 (fr) * 1996-05-27 1997-12-04 UZILOVA, Irina Semenovna, Heiress of UZILOV Utilisation de souches de streptococcus faecium et composition a base de ces souches
SE511648C2 (sv) * 1998-04-17 1999-11-01 Bacterum Ab Streptokockpreparat för behandling av öroninflammation
WO2008109669A2 (en) * 2007-03-05 2008-09-12 Om Pharma Bacterial extract for respiratory disorders and proces for its preparation
CN104922330A (zh) * 2015-07-15 2015-09-23 龚灿锋 一种治疗扁桃体炎的中药

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE543985A (enrdf_load_stackoverflow) *
FR2892M (fr) * 1963-07-25 1964-11-02 Inst Rech Scient Substances a action immunisante et désensibilisante.
FR6513M (enrdf_load_stackoverflow) * 1967-07-12 1968-12-02
FR7010M (enrdf_load_stackoverflow) * 1967-11-10 1969-06-02
FR7461M (enrdf_load_stackoverflow) * 1968-06-19 1970-01-05
FR2043475A1 (enrdf_load_stackoverflow) * 1969-05-20 1971-02-19 Cassenne Lab Sa
FR2171907A2 (enrdf_load_stackoverflow) * 1972-02-15 1973-09-28 Cassenne Lab Sa
FR2253499A1 (enrdf_load_stackoverflow) * 1973-12-10 1975-07-04 Fabre Sa Pierre
US3929994A (en) * 1969-05-20 1975-12-30 Roussel Uclaf Anti-inflammatory glycoprotein compositions and method of use
FR2283697A1 (fr) * 1974-09-06 1976-04-02 Irceba Composition nasale contenant des antigenes d'origine bacterienne
FR2307542A1 (fr) * 1975-04-14 1976-11-12 Synthelabo Nouvelle preparation immunostimulante
FR2315944A1 (fr) * 1975-07-04 1977-01-28 Tournade Francois Preparation pharmaceutique presentant une action de stimulation immunitaire non specifique de l'organisme

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE543985A (enrdf_load_stackoverflow) *
FR2892M (fr) * 1963-07-25 1964-11-02 Inst Rech Scient Substances a action immunisante et désensibilisante.
FR6513M (enrdf_load_stackoverflow) * 1967-07-12 1968-12-02
FR7010M (enrdf_load_stackoverflow) * 1967-11-10 1969-06-02
FR7461M (enrdf_load_stackoverflow) * 1968-06-19 1970-01-05
FR2043475A1 (enrdf_load_stackoverflow) * 1969-05-20 1971-02-19 Cassenne Lab Sa
US3929994A (en) * 1969-05-20 1975-12-30 Roussel Uclaf Anti-inflammatory glycoprotein compositions and method of use
FR2171907A2 (enrdf_load_stackoverflow) * 1972-02-15 1973-09-28 Cassenne Lab Sa
FR2253499A1 (enrdf_load_stackoverflow) * 1973-12-10 1975-07-04 Fabre Sa Pierre
FR2283697A1 (fr) * 1974-09-06 1976-04-02 Irceba Composition nasale contenant des antigenes d'origine bacterienne
FR2307542A1 (fr) * 1975-04-14 1976-11-12 Synthelabo Nouvelle preparation immunostimulante
FR2315944A1 (fr) * 1975-07-04 1977-01-28 Tournade Francois Preparation pharmaceutique presentant une action de stimulation immunitaire non specifique de l'organisme

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550707A1 (fr) * 1983-08-17 1985-02-22 Lipha Medicament immunomodulateur d'origine biologique et son procede de preparation
EP0139551A3 (en) * 1983-08-17 1985-07-10 Lipha, Lyonnaise Industrielle Pharmaceutique Immunomodulating medicine of biological origin, and process for preparing it

Also Published As

Publication number Publication date
DE2917730C2 (de) 1986-04-03
CH633188A5 (fr) 1982-11-30
RO78451A (ro) 1982-02-26
YU123679A (en) 1983-04-30
GB2021415B (en) 1983-03-30
YU41864B (en) 1988-02-29
HU180005B (en) 1983-01-28
PL126416B1 (en) 1983-08-31
IT1116213B (it) 1986-02-10
PT69674A (pt) 1979-06-01
GB2021415A (en) 1979-12-05
BE876164A (fr) 1979-09-03
JPS6337770B2 (enrdf_load_stackoverflow) 1988-07-27
ES480448A1 (es) 1979-12-16
JPS54154509A (en) 1979-12-05
CS222673B2 (en) 1983-07-29
DE2917730A1 (de) 1979-11-29
PL215824A1 (enrdf_load_stackoverflow) 1980-02-11
DD143729A5 (de) 1980-09-10
FR2426470B1 (enrdf_load_stackoverflow) 1983-08-05
IT7949157A0 (it) 1979-05-24

Similar Documents

Publication Publication Date Title
Comber et al. Comparative effects of amoxycillin and ampicillin in the treatment of experimental mouse infections
KR0165132B1 (ko) 포도상구균 항균제
FR2426470A1 (fr) Medicament immunobiotherapique contre des maladies infectieuses des voies respiratoires
US5834424A (en) Use of lactoferrin for therapy of acute of chronic infectious diseases by the intracellular gram-positive pathogens streptococcus pyogenes and staphylococcus aureus
Shurin et al. Otitis media caused by non-typable, ampicillin-resistant strains of Haemophilus influenzae
Smith et al. Wound healing: an experimental study of water soluble chlorophyll derivatives in conjunction with various antibacterial agents
CLARKE TOPICAL USE OF SILVER SULPHADIAZINE AND CHLORHEXIDINE IN THW PREVENTION OF INFECTION IN THERMAL INJURIES
Howells et al. Two outbreaks of neonatal skin sepsis caused by Staphylococcus aureus, phage type 71
KR910015306A (ko) 피부염 치료용 약제
FR2376661A1 (fr) Medicaments anthelminthiques renfermant comme substances actives des anilinomethylene-malononitriles
Baird et al. Contaminated medicaments in use in a hospital for diseases of the skin
CN107951733A (zh) 薁黄酸钠和西吡氯铵复方漱口水的制备及其应用
Ginsburg Streptococcus.
Mellon et al. Therapy of experimental staphylococcus infections with sulfonamide compounds
Bacayo et al. The study of the antibacterial activity of asam gelugor (Garcinia atroviridis) against methecillin-resistant Staphylococcus aureus (MRSA), Streptococcus pneumoniae and Klebseilla pneumoniae
KEITH et al. Subacute bacterial endocarditis due to hemolytic streptococci of Lancefield group G
Barlow Relative Toxicities and Therapeutic Values of Three Chemo-therapeutic Agents of the Sulphonamide Type
FR2307542A1 (fr) Nouvelle preparation immunostimulante
ES2005057A4 (es) Lisados bacterianos antigenicos, un proceso para la preparacion de estos y compuestos farmaceuticos que los contienen.
FR2143557A1 (en) Antimicrobial n-acyl basic amino acid derivs - useful as antiseptics, preservatives, disinfectants etc
Light et al. Decreased colonization of newborn infants with Staphylococcus aureus 80/81: Cincinnati General Hospital, 1960–1972
CN107753931A (zh) 乳酸链球菌素、西吡氯铵和氟化钠复方啫喱的制备及应用
Moroney Sore throat
Collins et al. The Treatment of Chronic Supprative Otitis Media by the Local Application of Pencillin and Other Drugs
Platou et al. Round table discussion on antibiotics

Legal Events

Date Code Title Description
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0296, 920526

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0296, 790523

CL Concession to grant licences
CD Change of name or company name